Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Genentech

    Client Virtual Booth

    GENENTECH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Genentech
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 DNA Way, South San Francisco, CA 94080
    Telephone
    Telephone
    +1-650-225-1000, +1 (800) 626-3553
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gene.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer
    FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

    https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-alectinib-adjuvant-treatment-alk-positive-non-small-cell-lung-cancer#:~:text=On%20April%2018%2C%202024%2C%20the,by%20an%20FDA%2Dapproved%20test.

    FDA
    19 Apr 2024
    Share Share
    Alecensa approved as 1st adjuvant for ALK+ early lung cancer
    Alecensa approved as 1st adjuvant for ALK+ early lung cancer

    https://www.businesswire.com/news/home/20240418088206/en

    BUSINESSWIRE
    18 Apr 2024
    Share Share
    Roche’s Columvi offers survival benefit in Phase III DLBCL trial
    Roche’s Columvi offers survival benefit in Phase III DLBCL trial

    https://www.clinicaltrialsarena.com/news/roche-columvi-survival-benefit/

    CLINICALTRIALSARENA
    15 Apr 2024
    Share Share
    Genentech's Columvi Meets DLBCL STARGLO Survival Endpoint
    Genentech's Columvi Meets DLBCL STARGLO Survival Endpoint

    https://www.businesswire.com/news/home/20240414728020/en

    BUSINESSWIRE
    15 Apr 2024
    Share Share
    Genentech’s Columvi Meets Primary Endpoint Ref. Diffuse Large B-Cell Lymphoma
    Genentech’s Columvi Meets Primary Endpoint Ref. Diffuse Large B-Cell Lymphoma

    https://www.gene.com/media/press-releases/15021/2024-04-14/genentechs-columvi-meets-primary-endpoin

    PRESS RELEASE
    15 Apr 2024
    Share Share
    Genentech plans to cut 3% of workforce across several units, company says
    Genentech plans to cut 3% of workforce across several units, company says

    https://endpts.com/exclusive-genentech-plans-to-cut-3-of-workforce-across-several-units-company-says/

    Kyle LaHucik ENDPTS
    10 Apr 2024
    Share Share
    Seagen’s former commercial chief joins the board at healthcare agency
    Seagen’s former commercial chief joins the board at healthcare agency

    https://endpts.com/seagens-former-commercial-chief-joins-the-board-at-healthcare-agency-minds-assembly/

    Beth Snyder Bulik ENDPTS
    22 Mar 2024
    Share Share
    Genentech`s Biologic Xolair (omalizumab) Receives Approval in the U.S.
    Genentech`s Biologic Xolair (omalizumab) Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103976

    FDA
    16 Feb 2024
    Share Share
    Genentech`s Biologic Lucentis (ranibizumab) Receives Approval in the U.S.
    Genentech`s Biologic Lucentis (ranibizumab) Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125156

    FDA
    15 Feb 2024
    Share Share
    Genentech`s Biologic Pulmozyme (dornase alfa) Receives Approval in the U.S.
    Genentech`s Biologic Pulmozyme (dornase alfa) Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103532

    FDA
    09 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search